Kompass Diagnostics develops a point-of-care platform for rapid hormone diagnostics to support fertility treatment workflows. The system uses proprietary test cartridges and an analyzer to deliver quantitative results from whole blood samples in under ten minutes. This technology streamlines laboratory processes, making essential hormone testing faster and more accessible for clinical decision-making.
Funding
$1.6M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
BIFounders
Product
Problem
Many couples face significant barriers to accessing fertility treatments, including high costs, lack of insurance coverage, and limited access to nearby fertility clinics. Traditional fertility testing often requires in-person lab visits, which can be inconvenient and expensive. This lack of access can delay diagnosis and treatment, impacting a couple's ability to conceive.
Solution
Kompass Diagnostics offers a point-of-care platform for fertility treatment, enabling remote monitoring of key fertility hormone levels. The system utilizes a portable, easy-to-use device that allows individuals to collect samples via a simple finger prick, either at home or with medical assistance. The device measures eight fertility hormones that guide clinical decisions. By connecting patients directly with healthcare providers and offering a more affordable testing option, Kompass aims to break down barriers to fertility care and improve the patient experience.
Target Audience
The primary target audience includes couples seeking fertility treatment, reproductive-aged women with limited access to fertility clinics, and healthcare providers looking for cost-effective remote monitoring solutions.
Features
- Portable, finger-prick based hormone monitoring device for remote sample collection.
- Measures eight key fertility hormones relevant for clinical decision-making.
- Connects patients with healthcare providers for safe communication and consultation.
- Low-cost alternative to traditional in-person lab tests, reducing expenses by up to 90%.